(Q38318462)

2 September 2017

title

Lithium's gene expression profile, relevance to neuroprotection A cDNA microarray study (English)

1 reference

2 September 2017

4

Moussa B H Youdim

1 reference

2 September 2017

5

Zaher Arraf

1 reference

2 September 2017

Raymond Farah

1

1 reference

2 September 2017

Rola Khamisy-Farah

series ordinal

2

1 reference

2 September 2017

Tamar Amit

series ordinal

3

1 reference

2 September 2017

publication date

17 January 2013

1 reference

Cellular and Molecular Neurobiology

2 September 2017

published in

1 reference

2 September 2017

volume

33

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

411-420

1 reference

https://scigraph.springernature.com/pub.10.1007/s10571-013-9907-x

2 September 2017

exact match

0 references

cites work

Lithium and oxidative stress lessons from the MPTP model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Experimental models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

An update on regional brain volume differences associated with mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Neuroprotective effects of lithium in cultured cells and animal models of diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

The NMDA receptor/nitric oxide pathway: a target for the therapeutic and toxic effects of lithium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

AP-1, CREB and CBP transcription factors differentially regulate the tyrosine hydroxylase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

The impact of the discovery of lithium on psychiatric thought and practice in the USA and Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Powerful tools for genetic analysis come of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Effects of subchronic lithium treatment on levels of BDNF, Bcl-2 and phospho-CREB in the rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Fluoxetine upregulates phosphorylated-AKT and phosphorylated-ERK1/2 proteins in neural stem cells: evidence for a crosstalk between AKT and ERK1/2 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Lithium and brain signal transduction systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

ERK/MAPK is essential for endogenous neuroprotection in SCN2.2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Chronic lithium treatment antagonizes glutamate-induced decrease of phosphorylated CREB in neurons via reducing protein phosphatase 1 and increasing MEK activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Mood-stabilizing drugs: are their neuroprotective aspects clinically relevant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Long-term action of lithium: a role for transcriptional and posttranscriptional factors regulated by protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Signal transduction pathways. Molecular targets for lithium's actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

MRI study of thalamus volumes in juvenile patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Lithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Cyclin-dependent kinase 5 phosphorylates the N-terminal domain of the postsynaptic density protein PSD-95 in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Statistical issues with microarrays: processing and analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Characterization and expression of mammalian cyclin b3, a prepachytene meiotic cyclin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Opposed effects of lithium on the MEK-ERK pathway in neural cells: inhibition in astrocytes and stimulation in neurons by GSK3 independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

CREB mediates the cAMP-responsiveness of the tyrosine hydroxylase gene: use of an antisense RNA strategy to produce CREB-deficient PC12 cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Lithium inhibits glycogen synthase kinase-3 by competition for magnesium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Neuroprotection by MAPK/ERK kinase inhibition with U0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Short chain fatty acids induce TH gene expression via ERK-dependent phosphorylation of CREB protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Neuroimaging studies of mood disorder effects on the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

The anatomy of mood disorders--review of structural neuroimaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Estradiol and lithium chloride specifically alter NMDA receptor subunit NR1 mRNA and excitotoxicity in primary cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Role of the cyclic AMP response element in the bcl-2 promoter in the regulation of endogenous Bcl-2 expression and apoptosis in murine B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Selective alterations of transcription factors in MPP+-induced neurotoxicity in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

MAPK signal pathways in the regulation of cell proliferation in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Cdk5 regulates the phosphorylation of tyrosine 1472 NR2B and the surface expression of NMDA receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Lithium chloride induces the expression of tyrosine hydroxylase in hNT neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-013-9907-X

Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?

21 January 2018

1 reference

12 December 2020

Enhancement of hippocampal neurogenesis by lithium

1 reference

12 December 2020

Lithium increases tyrosine hydroxylase levels both in vivo and in vitro.

1 reference

12 December 2020

Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.

1 reference

12 December 2020

Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity.

1 reference

12 December 2020

Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice.

1 reference

12 December 2020

Lithium-induced increase in human brain grey matter

1 reference

12 December 2020

Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model.

1 reference

12 December 2020

Effects of lithium on the activity of ERK-1/2 signal pathway and expression of Bcl-2 family proteins in the central nervous system in vivo

1 reference

12 December 2020

Expression profiling using cDNA microarrays

1 reference

12 December 2020

Restraint stress influences AP-1 and CREB DNA-binding activity induced by chronic lithium treatment in the rat frontal cortex and hippocampus.

1 reference

12 December 2020

Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy

1 reference

12 December 2020

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2.

1 reference

12 December 2020

Lithium activates the c-Jun NH2-terminal kinases in vitro and in the CNS in vivo

1 reference

12 December 2020

Lithium salts in the treatment of psychotic excitement. 1949.

1 reference

12 December 2020

10.1007/S10571-013-9907-X

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

1027571004

0 references

1 reference